175 related articles for article (PubMed ID: 20469978)
41. Rubella susceptibility predicts measles susceptibility: implications for postpartum immunization.
Libman MD; Behr MA; Martel N; Ward BJ
Clin Infect Dis; 2000 Dec; 31(6):1501-3. PubMed ID: 11096023
[TBL] [Abstract][Full Text] [Related]
42. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
[TBL] [Abstract][Full Text] [Related]
43. Rubella seroprevalence among young women taipei county after routine measles, mumps and rubella immunization program.
Wang IJ; Hwang KC; Tsai YH; Wu YN; Chao SJ; Chen TE; Huang LM
Acta Paediatr Taiwan; 2006; 47(1):14-7. PubMed ID: 17016964
[TBL] [Abstract][Full Text] [Related]
44. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
[TBL] [Abstract][Full Text] [Related]
45. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
[TBL] [Abstract][Full Text] [Related]
46. Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine.
LeBaron CW; Forghani B; Matter L; Reef SE; Beck C; Bi D; Cossen C; Sullivan BJ
J Infect Dis; 2009 Sep; 200(6):888-99. PubMed ID: 19659440
[TBL] [Abstract][Full Text] [Related]
47. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.
Ovsyannikova IG; Pankratz VS; Vierkant RA; Jacobson RM; Poland GA
J Infect Dis; 2006 Mar; 193(5):655-63. PubMed ID: 16453260
[TBL] [Abstract][Full Text] [Related]
48. Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia.
Ercan TE; Soycan LY; Apak H; Celkan T; Ozkan A; Akdenizli E; Kasapçopur O; Yildiz I
J Pediatr Hematol Oncol; 2005 May; 27(5):273-7. PubMed ID: 15891564
[TBL] [Abstract][Full Text] [Related]
49. Response to measles-mumps-rubella vaccine in children with autism spectrum disorders.
Gentile I; Bravaccio C; Bonavolta R; Zappulo E; Scarica S; Riccio MP; Settimi A; Portella G; Pascotto A; Borgia G
In Vivo; 2013; 27(3):377-82. PubMed ID: 23606694
[TBL] [Abstract][Full Text] [Related]
50. Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry.
Ramondetti F; Sacco S; Comelli M; Bruno G; Falorni A; Iannilli A; d'Annunzio G; Iafusco D; Songini M; Toni S; Cherubini V; Carle F;
Diabet Med; 2012 Jun; 29(6):761-6. PubMed ID: 22133003
[TBL] [Abstract][Full Text] [Related]
51. Correlations between measles, mumps, and rubella serum antibody levels in Olmsted County school children.
St Sauver JL; Jacobson RM; Vierkant RA; Jacobsen SJ; Green EM; Schaid DJ; Poland GA
Vaccine; 2001 Jan; 19(11-12):1363-8. PubMed ID: 11163657
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of serological status of rubella & mumps in children below five years.
Chakravarti A; Yadav S; Berry N; Rastogi A; Mathur MD
Indian J Med Res; 1999 Jul; 110():1-3. PubMed ID: 10709331
[TBL] [Abstract][Full Text] [Related]
53. [Prevalence of maternal measles, rubella, mumps and varicella antibodies in the first six months of life].
Devecioğlu E; Gökçay G; Boran P; Eren T; Yılmaz G; Badur S
Mikrobiyol Bul; 2018 Jul; 52(3):324-327. PubMed ID: 30156519
[TBL] [Abstract][Full Text] [Related]
54. Immunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without Infection.
Siberry GK; Patel K; Bellini WJ; Karalius B; Purswani MU; Burchett SK; Meyer WA; Sowers SB; Ellis A; Van Dyke RB; ;
Clin Infect Dis; 2015 Sep; 61(6):988-95. PubMed ID: 26060291
[TBL] [Abstract][Full Text] [Related]
55. [Effects of measles vaccination in HIV infected children].
Ołdakowska A; Marczyńska M; Szczepańska-Putz M
Przegl Epidemiol; 2001; 55(4):523-7. PubMed ID: 11921741
[TBL] [Abstract][Full Text] [Related]
56. Humoral immune response of childhood acute lymphoblastic leukemia survivors against the measles, mumps, and rubella vaccination.
Fouda AE; Kandil SM; Boujettif F; Salama YS; Fayea NY
Hematology; 2018 Oct; 23(9):590-595. PubMed ID: 29614919
[TBL] [Abstract][Full Text] [Related]
57. Australian population cohort study of newly arrived refugee children: how effective is predeparture measles and rubella vaccination?
Joshua PR; Smith MM; Koh AS; Woodland LA; Zwi K
Pediatr Infect Dis J; 2013 Feb; 32(2):104-9. PubMed ID: 22955722
[TBL] [Abstract][Full Text] [Related]
58. Measles and rubella antibody status in children after treatment for acute lymphoblastic leukemia.
Volc SM; Almeida MT; Abadi MD; Cornacchioni AL; Odone Filho V; Cristofani LM
J Pediatr (Rio J); 2006; 82(6):481-4. PubMed ID: 17003944
[TBL] [Abstract][Full Text] [Related]
59. Lower long-term immunogenicity of mumps component after MMR vaccine.
De Laval F; Haus R; Spiegel A; Simon F
Pediatr Infect Dis J; 2010 Nov; 29(11):1062-3; author reply 1063. PubMed ID: 20975455
[No Abstract] [Full Text] [Related]
60. Antibody dynamics after tick-borne encephalitis and measles-mumps-rubella vaccination in children post early thymectomy.
Zlamy M; Würzner R; Holzmann H; Brandstätter A; Jeller V; Zimmerhackl LB; Prelog M
Vaccine; 2010 Nov; 28(51):8053-60. PubMed ID: 20955827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
